Targeted suppression of tumor growth by CREPT promoter-driven diphtheria toxin fragment A.

Despite significant advancements in diagnosis and treatment, cancer remains a leading cause of mortality globally. Cancer gene therapy has emerged as a promising strategy, with numerous clinical trials demonstrating its efficacy in targeting tumor ce…

Preview only. Read the full abstract at the source